Recruiting studies: Response Acute Phase

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
Phase 1/Phase 2 · 3 location(s) · St. Jude Children's Research Hospital · NCT04195347 rTMS Response Trajectories in Depression
NA · 1 location(s) · Chinese University of Hong Kong · NCT03348761 A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kid
Phase 2 · 72 location(s) · AstraZeneca · NCT07215702 Two Schemes Response in Multiple Myeloma
Phase N/A · 1 location(s) · Hospital General de Mexico · NCT06284395 Efficacy and Safety of YD0743 Treatment for Sepsis-Associated ARDS
Phase 2 · 1 location(s) · Shanghai Yidian Pharmaceutical Technology Development Co., L · NCT07413094 Corticosteroids in Hyperinflammatory Phenotype of Critical Illness
Phase 2 · 1 location(s) · Bin Du · NCT07511582 Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit fo
Phase 4 · 1 location(s) · University Hospital, Strasbourg, France · NCT06881927 "Effect of Ibuprofen on Acute Inflammatory Response After One-Stage Periodontal Therapy"
Phase 4 · 1 location(s) · University of Baghdad · NCT07459049 NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)
Phase 2/Phase 3 · 4 location(s) · Health Institutes of Turkey · NCT07502118 Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury
Phase 1/Phase 2 · 2 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT07236463 Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With
Phase 1/Phase 2 · 1 location(s) · Hospital General Universitario Gregorio Marañon · NCT06052436 Assessing Cancer Treatment Response to Therapy Using 18F-FSPG PET
Phase N/A · 1 location(s) · Guy's and St Thomas' NHS Foundation Trust · NCT05889312 Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin
Phase 2 · 36 location(s) · National Cancer Institute (NCI) · NCT06917911

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.